Raymond James analyst Brian MacArthur initiated coverage of Uranium Royalty (UROY) with an Outperform rating and C$4.50 price target The firm says Uranium is “unique” as the largest publicly traded uranium focused royalty company. It believes royalty companies like Uranium offer equity investors exposure to commodity prices while mitigating downside risk given limited exposure to operating and capital costs. At the same time, upside optionality exists through exploration and asset expansion potential, the analyst tells investors in a research note.